Delivery Order SPE2DB22D3301-SPE2DB25FZ1KH
- Not listed
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,185.38 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 30 mg tablets (100-count units). The contract, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, was competitively awarded with no set-aside designation and is structured as a firm fixed-price delivery order. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,300.23 to AmerisourceBergen Drug Corp for OxyContin ER 80 mg tablets (100-count packaging) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,802.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 22, 2025, for the supply of OxyContin ER 40 mg tablets (100-count packages) at a ceiling value of $8,696.13. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The order is scheduled for ultimate completion on May 23, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,437.52 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units). The contract is classified as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a contract value of $2,783.05. This delivery order represents a firm fixed price, non-set-aside competitive award supporting federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1KHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,542.62 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 80 mg tablets (100-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting portfolio demonstrates extensive experience fulfilling pharmaceutical procurement requirements across multiple therapeutic domains, with AmerisourceBergen positioned as a critical vendor within the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/23/25 |